SYNAREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synarel, and what generic alternatives are available?
Synarel is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.
Summary for SYNAREL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 3 |
Patent Applications: | 442 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SYNAREL |
What excipients (inactive ingredients) are in SYNAREL? | SYNAREL excipients list |
DailyMed Link: | SYNAREL at DailyMed |
Recent Clinical Trials for SYNAREL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Diego | Early Phase 1 |
Shaare Zedek Medical Center | N/A |
New Hope Fertility Center | N/A |
Pharmacology for SYNAREL
Drug Class | Gonadotropin Releasing Hormone Receptor Agonist |
Mechanism of Action | Gonadotropin Releasing Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for SYNAREL
US Patents and Regulatory Information for SYNAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SYNAREL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | SYNAREL | nafarelin acetate | SPRAY, METERED;NASAL | 019886-001 | Feb 13, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SYNAREL
See the table below for patents covering SYNAREL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hungary | 185379 | PROCESS FOR THE PRODUCTION OF THE NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF THE LUTEOTROPE RELEASING FACTOR | ⤷ Try a Trial |
United Kingdom | 2054603 | NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LUTEINIZING HORMONE RELEASING HORMONE | ⤷ Try a Trial |
Norway | 801729 | ⤷ Try a Trial | |
Greece | 69259 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SYNAREL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0021234 | 93C0049 | Belgium | ⤷ Try a Trial | PRODUCT NAME: NAFARELIN. ACETAT; NAT. REG.: 194 IS 46 F 11 19920616; FIRST REG.: DK D.SP.NR. 8291 19900628 |
0021234 | SPC/GB93/056 | United Kingdom | ⤷ Try a Trial | SPC/GB93/056, EXPIRES: 20050609 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |